Global PRMT 5 Inhibitors Market, By Disease (Heart disease, Infectious disease and Cancer), By Function (Transcriptional regulation, Cell cycle regulation and Others) By End-user (Specialty Clinics, Research & laboratories, Academic research and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI472121 | Publish Date: July 2021 | No. of Pages: 168

Global PRMT 5 Inhibitors Market Companies

  • laxoSmithKline Plc.
  • Janssen
  • Merck
  • Mirati Therapeutics Inc.

Recent News:

  • According to PubMed Central article, Protein arginine methyltransferase 5 (PRMT5) inhibitors are a new class of antineoplastic agents showing promising preliminary clinical efficacy. Targeting an enzyme involved in a wide array of cellular and transcriptional pro-oncogenic processes, this class offers multifaceted tumor-suppressive effects.